Navigation Links
Closed Drug Transfer Systems: Oncology Therapeutics Market Dynamics and Closed Drug Transfer Design Factors - Market Forecasts to 2017
Date:6/6/2013

DUBLIN, June 6, 2013 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/qs2bc8/closed_drug) has announced the addition of the "Closed Drug Transfer Systems. Therapeutic Markets, Strategies and Outlook" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769)

The administration of drugs deemed hazardous to humans has been receiving increasing amounts of scrutiny in recent years as the dangers of these substances become more clearly understood.

For caregivers and their patients, the therapeutic area that is at the forefront of attempts to mitigate exposure to cytotoxic drugs is clinical oncology, a field that - in spite of promising new drugs based on therapeutic antibodies - continues to rely heavily on antineoplastics, a class that includes alkylating agents and antimetabolites, to treat a wide range of cancers. Regulatory and industry efforts to create standards and procedures designed to protect workers and patients from accidental and incidental exposure to cytotoxics are being driven by data that suggests a causal link between exposure and health issues. Studies of nurses who work with cytotoxic drugs on a regular basis have found a statistically higher rate of spontaneous abortion.

Several companies are responding to this unmet need by commercializing devices for closed transfer of these drugs. As the market evolves and user acceptance increases, so too will the impact of these products on oncology therapy protocols and drug delivery.

Highlights

- Analyzes the impact of drug toxicity and safety factors on therapeutic oncology market segments, market dynamics and market demographics

- Provides detailed analysis of closed drug transfer products for the handing of cytotoxic drugs

- Analyzes demand drivers and competitive factors influencing closed drug transfer adoption

- Charts product data and provides forecasts to 2017

- Profiles closed drug transfer device participants, their product development activities, business strategies, and corporate alliances and affiliations

Key Topics Covered:

Executive Summary

Oncology Therapeutics Market Dynamics 

Therapeutic Trends and Issues
The Administration of injectable/Infusable Antineoplastics
Drug Packaging and Administration Technology
Closed Drug Transfer Market Drivers
Competitive Landscape
Risk Factors

Closed Drug Transfer Design Factors

Key System Design Elements
Human Engineering/Ergonomics
Material Selection Issues
Drug Reconstitution and Dilution
Oncology Therapeutics Medication Safety
Oncology Drug Administration and Dosing
Drug-Specific Dosing Modification and Individualized Dosing

Closed Drug Transfer - Commercial Device Assessments and Market Data 

Market Factors

Regulatory Issues
Caregiver Compliance
Level of Complexity and Ease of Use
Healthcare Economics
Business Models and Strategies

Market Assessments and Forecasts

North America
Europe
Asia
Other Geographic Markets

Closed Drug Transfer - Market Participant Profiles

For more information visit http://www.researchandmarkets.com/research/qs2bc8/closed_drug

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Research and Markets
Laura Wood , Senior Manager.
press@researchandmarkets.com
U.S. Fax: +1-646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Drug Delivery



'/>"/>
SOURCE Research and Markets
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Aesthetics Pharmaceutical Company Selects 360 Vantage Closed Loop Marketing Solution for Apple iPad
2. BellBrook Labs Launches Four New Turn-Key Methyltransferase Assay Kits
3. The Research Foundation for The State University of New York Enters Site License Agreement with 2Market Information Inc., Publisher of Technology Transfer Tactics
4. BellBrook Labs and BMG Labtech to Offer Webinar on Integrated Platform for Screening Kinases and Methyltransferases
5. Cyber Infrastructure Pvt. Ltd. (CIS) Begins Offering BOT (Build-Operate-Transfer) IT-Outsourcing Model for SMEs
6. Susterra® Propanediol Used in Greenway® Solar Heat Transfer Fluids
7. Nature Materials study: Boosting heat transfer with nanoglue
8. Physicists skirt thermal vibration, transfer optical signal via mechanical oscillator
9. Scientists target bacterial transfer of resistance genes
10. Ambit Announces Presentation of Results from Phase 2 ACE Study of Quizartinib in Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML) at the Annual Meeting of the American Society of Clinical Oncology
11. AbbVie Presents Results from Phase I Study of Investigational Oncology Compound ABT-199 at American Society of Clinical Oncology Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... 27, 2017 DarioHealth Corp. (NASDAQ: DRIO), a ... big data solutions, today announced that it is now ... for U.S. consumers who want to have their DarioHealth ... signed strategic alliance agreements with partners across the U.S. ... and if approved, will supply and bill the customer,s ...
(Date:3/24/2017)... Research and Markets has announced the addition ... Strategic Business Report" report to their offering. ... This report analyzes the Global ... Annual estimates and forecasts are provided for the period 2014 through ... research. The report profiles 25 companies including many ...
(Date:3/24/2017)... 2017 Agenus Inc. (NASDAQ: AGEN), an immuno-oncology ... cancer vaccines, today announced participation at the following conferences: ... Blair and Maidstone Life Sciences conference "Cancer Immunotherapy Conference" ... New York, NY . Agenus will participate ... 9:40 am: Robert B. Stein , M.D., Ph.D., ...
(Date:3/23/2017)... Md. , March 23, 2017  Northwest ... developing DCVax® personalized immune therapies for solid tumor ... the $7.5 million financing it announced last Friday, ... sold to several institutional investors securities totaling 28,843,692 ... per share, and 10,000,000 shares of Class C ...
Breaking Biology Technology:
(Date:3/23/2017)... Research and Markets has announced the addition of the ... to 2025" report to their offering. ... The Global Vehicle Anti-Theft System Market ... the next decade to reach approximately $14.21 billion by 2025. ... for all the given segments on global as well as regional ...
(Date:3/20/2017)... Pa. , March 20, 2017 PMD ... 2.0 personal spirometer and Wellness Management System (WMS), a ... Founded in 2010, PMD Healthcare is a Medical ... with a mission dedicated to creating innovative solutions that ... life. With that intent focus, PMD developed the first ...
(Date:3/7/2017)... BRIGHTON, England , March 7, 2017 Brandwatch ... been chosen by The Prince,s Trust to uncover insights ... insights across The Trust. The UK,s leading youth charity ... track social campaign results and get a better understanding of the ... ...
Breaking Biology News(10 mins):